Modulating macrophage function with IgG immune complexes
- 1 December 2002
- journal article
- Published by SAGE Publications in Innate Immunity
- Vol. 8 (6) , 477-481
- https://doi.org/10.1177/09680519020080060501
Abstract
Macrophages respond to bacterial products by releasing a large array of inflammatory mediators. We demonstrate that, in the presence of IgG immune complexes, macrophages produce high levels of IL-10 and virtually no IL-12, when they are exposed to bacterial products. The production of IL-10 by these cells can dampen innate inflammatory responses to microbial products, such as LPS. This alteration in macrophage cytokine production can also influence an adaptive immune response, preferentially inducing Th2-type immunity. Thus, immune complexes change the physiology of activated macrophages, converting them to anti-inflammatory cells that induce Th2-like immune responses. We have termed these cells type II activated macrophages.Keywords
This publication has 11 references indexed in Scilit:
- A novel phenotype for an activated macrophage: the type 2 activated macrophageJournal of Leukocyte Biology, 2002
- Cutting Edge: Biasing Immune Responses by Directing Antigen to Macrophage Fcγ ReceptorsThe Journal of Immunology, 2002
- Reversing Lipopolysaccharide Toxicity by Ligating the Macrophage Fcγ ReceptorsThe Journal of Immunology, 2001
- Critical Roles of Toll-Like Receptors in Host DefenseCritical Reviews in Immunology, 2000
- CYTOKINES AND ANTICYTOKINES IN THE PATHOGENESIS OF SEPSISInfectious Disease Clinics of North America, 1999
- Reversal of Proinflammatory Responses by Ligating the Macrophage Fcγ Receptor Type IThe Journal of Experimental Medicine, 1998
- Selective Suppression of Interleukin-12 Induction after Macrophage Receptor LigationThe Journal of Experimental Medicine, 1997
- Interleukin 10 protects mice against staphylococcal enterotoxin B-induced lethal shockInfection and Immunity, 1993
- Interleukin 10 protects mice from lethal endotoxemia.The Journal of Experimental Medicine, 1993
- Interleukin 10 reduces the release of tumor necrosis factor and prevents lethality in experimental endotoxemia.The Journal of Experimental Medicine, 1993